627527-04-2 Usage
Appearance
White crystalline solid
Usage
Intermediate in the synthesis of pharmaceuticals and other organic compounds
Classification
Halogenated aromatic alcohol
Structural features
Contains both bromine and fluorine atoms attached to a phenyl ring
Application
Commonly used in organic synthesis and medicinal chemistry
Role
Acts as a versatile building block for the construction of more complex molecules
Reactivity
Unique structure and reactivity make it a valuable tool for the creation of new drugs and other biologically active compounds
Check Digit Verification of cas no
The CAS Registry Mumber 627527-04-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,7,5,2 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 627527-04:
(8*6)+(7*2)+(6*7)+(5*5)+(4*2)+(3*7)+(2*0)+(1*4)=162
162 % 10 = 2
So 627527-04-2 is a valid CAS Registry Number.
627527-04-2Relevant articles and documents
NEW MACROCYCLIC LRRK2 KINASE INHIBITORS
-
Page/Page column 158-159, (2021/11/13)
Compounds of formula (I): wherein R, X1, X2, X3, Z1, Z2, Z3, A and Ra are as defined in the description. Medicaments.
NK-1 AND SEROTONIN TRANSPORTER INHIBITORS
-
Page/Page column 82, (2010/11/28)
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or serotonin or both.
Substituted imidazol-pyridazine derivatives
-
Page 21, (2010/02/05)
The present invention relates to compounds of formula wherein A is an unsubstituted or substituted cyclic group; and R is hydrogen or lower alkyl; or a pharmaceutically acceptable acid addition salt thereof. These compounds are NMDA NR-2B receptor subtype specific blockers and are useful in the treatment of neurodegeneration, depression and pain.
